Charles River Laboratories | CRL - أصول متداولة





أصول متداولة تغيير تاريخ
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Cardinal Health USD 38.06B 1.17B 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Cigna USD 43.03B 4.78B 2026-03
Concord Medical Services Hldg CNY 1.03B 174.49M 2025-06
CVS Health USD 74.82B 103M 2026-03
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 1.85B 178M 2026-03
Elevance Health USD 67.18B 152M 2026-06
Humana USD 38.08B 5.35B 2026-03
Illumina USD 2.74B 551M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Intrexon USD 23.72M 45.04M 2024-06
IQVIA Holdings USD 6.22B 29M 2026-03
Laboratory Of America USD 4.56B 538.3M 2026-03
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Lonza CHF 8B 3.41B 2025-12
McKesson USD 57.21B 2.49B 2026-03
Merck EUR 14.16B 932M 2026-03
Mettler Toledo International USD 1.33B 30.76M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Quest Diagnostics USD 2.57B 188M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03
UnitedHealth USD 91.13B 545M 2026-03
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 3.72B 1.73B 2026-03
West Pharmaceutical Services USD 1.83B 151.4M 2026-03